ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Mitoxantrone hydrochloride liposome injection in the treatment of recurrent/metastatic head and neck cancers: A multicenter, open-label, single-arm, phase Ib study.

Yang, Hang; Wang, Xicheng; Zhang, Hong; Peng, Jiyong; Li, Weidong; Liu, Yanyan; Hu, Jianbing; Zhou, Hui; Zhang, Bing; Liu, Jixiang; Lin, Shunhuan; Luo, Hao; Hu, Jie; Li, Zhiming广东药学院; 广州医学院; 四川大学; 中山大学; 1; 东莞市人民医院
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2022-6-1
7阅读
引用收藏
分享
相关
加载中…
  • Combination of mitoxantrone hydrochloride liposome with pegaspargase in patients with extranodal NK/T-cell lymphoma: A phase I/II clinical trial
    Huang, Y.; Wu, T.; Hu, Y.; Li, Y.; Ma, J.; Guo, Y.; Zhou, H.; Yang, R.; Gong, Y.; Zhang, Q. Y.; Lin, L. E.; Zhou, R.; Liu, Y.; Pan, Z.; Xue, J.; Wang, D.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2022-09-09 To 2022-09-13.
  • Safety and efficacy of mitoxantrone hydrochloride liposome in patients with platinum-refractory or platinum-resistant ovarian cancer: A prospective, multicenter, open-label, single-arm, phase Ib clinical trial.
    Huang, Yu; Li, Rong; Li Guiling; Luo, Yanlin; Yang, Zhijun; Lou, Ge; Ouyang, Weiwei; Xie, Rong; Luo, Wuxia; Chen, Lixin; Zhou, QiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
  • Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter study
    Wang, J.; Jiang, P.; Wei, L.; Zou, L.; Li, X.; Wang, C.; Sun, X.; Ding, L.; Yuan, X.; Cheng, H.; Wu, D.; Cai, R.; Yin, R.; Zhang, J.; Qiu, H.; Wang, T.; Gao, K.; Zhuo, Y.; Zhang, Y.; Zhao, F.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2022-06-03 至 2022-06-07
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2022-06-01
起止页码
E18028-E18028
资助标注
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
收录
ISTP · SCIE

作者

  • Y

    Yang, Hang (第一作者)

  • W

    Wang, Xicheng

查看全部 14 位作者收起作者
  • Z

    Zhang, Hong

  • P

    Peng, Jiyong

  • L

    Li, Weidong

  • L

    Liu, Yanyan

  • H

    Hu, Jianbing

  • Z

    Zhou, Hui

  • Z

    Zhang, Bing

  • L

    Liu, Jixiang

  • L

    Lin, Shunhuan

  • L

    Luo, Hao

  • H

    Hu, Jie

  • L

    Li, Zhiming

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417